Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study

NCT: NCT07515261 · COMPLETED

NCT IDNCT07515261

StatusCOMPLETED

Start Date2023-03-10

Completion2024-05-01

Brief Summary

This study will evaluate the feasibility and preliminary efficacy of pBFS-guided TMS treatment at DMPFC in autism spectrum disorder comorbid with language delay.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑